Primary Care Issues in HIV Infection


CME Credit Available: 2.00 AMA PRA Category 1 Credits™
Level: Basic
Release Date: January 10, 2013
Date of Last Review/Update: December 1, 2017
Expiration Date: December 1, 2018

This Cases on the Web activity describes a case and presents various clinical decision points, each focusing on the primary medical care of a patient with HIV infection. At each decision point, learners should select the option that they think is most sound. Selecting the correct option links the learner to an extended discussion of the related medical findings, research-based evidence, and case management considerations.

To advance from one clinical decision point to the next, learners should click on the NEXT arrow located at the bottom of the page that discusses the best clinical option.

After reviewing the cases, learners may access the continuing medical education (CME) posttest questions and the course evaluation, both of which must be completed and submitted to receive credit. Please see the posttest form and course evaluation form for further instructions.

Learning Objectives

On completion of this activity, learners will be able to:

  • Describe the indications for HIV screening and characteristics of the HIV antibody test
  • Decide the general approach to primary care of an HIV-infected patient, including stratified management based on the CD4+ cell count, appropriate follow-up, and management of long-term complications
  • Identify health care maintenance issues relevant to the care of an HIV-infected patient, including immunizations; screening for coinfections, cancers, and other medical conditions; and general health issues
  • Manage a patient with a newly detectable HIV viral load, focusing on medication adherence and avoiding drug interactions
  • Develop a rational approach to the evaluation of new symptoms in an HIV-infected patient
  • Identify and treat depression in this patient population

Assessment of Needs

The IAS–USA offers this state-of-the-art activity as part of a nationwide CME effort for physicians on the evolving challenges of managing HIV disease. This activity examines the immunization needs and considerations for adults living with HIV infection.

Intended Audience

This Cases on the Web presentation is designed for physicians who are new to the practice of HIV medicine or are seeking to refresh their understanding of the standard elements of HIV care.

This activity is also relevant for other practitioners, including nurse practitioners, physician assistants, nurses, and pharmacists.

CME Information


The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The IAS–USA designates this enduring material for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This CME activity is offered from December 1, 2017, to December 1, 2018. Participants who successfully complete the activity posttest and submit the evaluation and registration forms are eligible to receive CME credit. Physicians (MDs, DOs, and international equivalents) may receive CME credit for completing this activity. Other health care practitioners will receive a certificate of participation.

Pharmacy Continuing Education Contact Hours

Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 2 hours (0.2 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
UAN # 0761-9999-17-254-H02-P

Program expires 8/1/2019.

Nursing Continuing Education Contact Hours

Educational Review Systems is an approved approver of continuing nursing education by the Alabama State Nursing Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Provider # 5-115. This program is approved for 2 hours of continuing nursing education.

Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida and the District of Columbia.

Program expires 8/1/2019.



Rebecca Glassman, MD
Dr Glassman is an instructor in medicine at Harvard Medical School and a primary care physician at Healthcare Associates at Beth Israel Deaconess Medical Center in Boston, Massachusetts. She is certified as an HIV specialist by the American Academy of HIV Medicine (AAHIVM).


Howard Libman, MD
Dr Libman is Professor of Medicine, Emeritus, at Harvard Medical School and Deputy Editor for Primary Care at UptoDate. Dr Libman is coeditor of the textbook, HIV, published by the American College of Physicians. He is a member of the Infectious Diseases Society of America national expert guidelines panel on HIV primary care and a core faculty member of the IAS–USA.

Disclosure of Financial Interests With Commercial Concerns

In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (ie, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.


Dr Glassman has no relevant financial relationships to disclose. (Updated 6/28/17)


Dr Libman has no relevant financial relationships to disclose. (Updated 6/14/17)

Grant Support

This activity is part of the IAS–USA national educational effort that is funded, in part, by charitable contributions from commercial companies. Per IAS–USA policy, any effort that uses commercial grants must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity, including its content, development, or selection of topics or speakers. Generous support for this activity has been received from the following contributors.

For our HIV effort

ViiV Healthcare

Gilead Sciences, Inc

Bristol-Myers Squibb
Janssen Therapeutics


For our viral hepatitis effort

Gilead Sciences, Inc


Cases on the Web Editorial Board

Members of the COW Editorial Board participate in a volunteer capacity. They are not compensated for their role in overseeing the program. Listed below are the COW Editorial Board members and their financial interests with commercial companies within the past 12 months from the date of disclosure. Click here to view the COW Editorial Board.

Drug and Product Disclaimer

This activity may contain information about the investigational uses of drugs or products that are not approved by the US Food and Drug Administration. Please consult full prescribing information before using any medication or product mentioned in this COW activity.

The views and opinions expressed herein are those of the faculty and do not necessarily represent the opinions or recommendations of the IAS–USA.

Contact Information

If you have any questions about this COW activity, please contact the IAS–USA:

425 California Street
Suite 1450
San Francisco, CA 94104-2120
Telephone: 415-544-9400
Fax: 415-544-9401
E-mail: info“at”